These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20560976)

  • 21. [Endothelin receptor antagonists in pulmonary arterial hypertension].
    Tokgöz HC; Can MM; Kaymaz C
    Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():9-15. PubMed ID: 20819750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-related pulmonary arterial hypertension: clinical presentation and management.
    Sitbon O
    AIDS; 2008 Sep; 22 Suppl 3():S55-62. PubMed ID: 18845923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of patients with pulmonary arterial hypertension at the time of death or deterioration to functional class IV: insights from the REVEAL Registry.
    Farber HW; Miller DP; Meltzer LA; McGoon MD
    J Heart Lung Transplant; 2013 Nov; 32(11):1114-22. PubMed ID: 24035189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostanoid therapy for pulmonary arterial hypertension.
    Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phosphodiesterase type 5 inhibitors in the treatment of pulmonary arterial hypertension].
    Kiliçkesmez K; Küçükoğlu MS
    Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():16-8. PubMed ID: 20819751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New and future therapies in pulmonary arterial hypertension.
    Bull TM
    Semin Respir Crit Care Med; 2005 Aug; 26(4):429-36. PubMed ID: 16121320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current recommendations for the diagnosis and treatment of pulmonary hypertension].
    Olschewski H
    Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S334-7. PubMed ID: 17139601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatments for pulmonary arterial hypertension.
    Liu C; Liu K; Ji Z; Liu G
    Respir Med; 2006 May; 100(5):765-74. PubMed ID: 16549344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Right ventricular adaptation and maladaptation in chronic pulmonary arterial hypertension.
    Rich S
    Cardiol Clin; 2012 May; 30(2):257-69. PubMed ID: 22548816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination treatment in pulmonary arterial hypertension].
    Kramer MR
    Harefuah; 2011 Apr; 150(4):383-8, 417. PubMed ID: 22164922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bleeding events in pulmonary arterial hypertension.
    Opitz CF; Kirch W; Mueller EA; Pittrow D
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():68-73. PubMed ID: 19335748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study.
    Bendayan D; Shitrit D; Kramer MR
    Respirology; 2008 Nov; 13(6):916-8. PubMed ID: 18811891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternatives to lung transplantation: treatment of pulmonary arterial hypertension.
    Corris PA
    Clin Chest Med; 2011 Jun; 32(2):399-410. PubMed ID: 21511098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective.
    Gomberg-Maitland M; Dufton C; Oudiz RJ; Benza RL
    J Am Coll Cardiol; 2011 Mar; 57(9):1053-61. PubMed ID: 21349396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment algorithm for pulmonary arterial hypertension].
    Hoeper MM
    Herz; 2005 Jun; 30(4):326-31. PubMed ID: 15965810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of pulmonary arterial hypertension in children.
    Roofthooft MT; van Loon RL; Berger RM
    Paediatr Respir Rev; 2010 Dec; 11(4):240-5. PubMed ID: 21109183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nebulized milrinone use in a pulmonary hypertensive crisis.
    Buckley MS; Feldman JP
    Pharmacotherapy; 2007 Dec; 27(12):1763-6. PubMed ID: 18041894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy improves exercise capacity and reduces risk of clinical worsening in patients with pulmonary arterial hypertension: a meta-analysis.
    Zhu B; Wang L; Sun L; Cao R
    J Cardiovasc Pharmacol; 2012 Oct; 60(4):342-6. PubMed ID: 22691882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.